Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

Metformin.

Research draft

Metformin is a small-molecule prescription medicine widely used for type 2 diabetes.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Metformin is a small-molecule prescription medicine widely used for type 2 diabetes.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It reduces hepatic glucose production through complex metabolic actions; it is not simply a universal AMPK activator.

Human research

Diabetes evidence is extensive. Human lifespan extension in otherwise healthy people is not established.

Preclinical & other research

Animal and cellular ageing findings generate hypotheses, not proven human longevity effects.

Safety & unknowns

Gastrointestinal effects, vitamin B12 changes and lactic-acidosis risk in susceptible settings matter.

Regulatory status

Approved diabetes treatment does not establish an approved anti-ageing indication.

Reported use & evidence

Research profile draft

The supplied Metformin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Follow the cited records and registered research. Profiles remain research drafts.

Explore more compounds